There is some relief for diabetes patients in India. According to recent news on May 10, 2024, the NPPA (National Pharmaceutical Pricing Authority) has reduced the prices of 41 essential… Continue Reading
WHO Report Reveals India’s Hepatitis Situation: Actions Needed
According to the latest report from the World Health Organization (WHO), hepatitis stands out as the leading communicable disease worldwide. Its death toll is alarmingly high, with approximately 1.3 million… Continue Reading
Zydus Introduces IBYRA, the Generic version of Olaparib, in India
Zydus launches generic version of cancer drug Olaparib in India, under brand name IBYRA In March 2024, a ground-breaking move aimed at transforming the landscape of cancer treatment in India,… Continue Reading
New Generic Harvoni Sofosbuvir Ledipasvir in India
Transmission, Symptoms, and Signals: * Transmission modes: blood contact, unsafe procedures, other routes (rare) * Symptoms: often silent, fatigue, digestive woes, changes in waste products * Importance of vaccination, early… Continue Reading
Affordable Sofosbuvir in India: Hope for the World’s Hepatitis C Patients
Hepatitis C, a silent liver disease affecting millions worldwide, can now be treated with remarkable success thanks to advancements like Sofosbuvir. However, the soaring cost of branded Sofosbuvir often puts… Continue Reading